U.S. News

WHO will take a decision in October on listing the vaccine for emergency use

(Yoshita Singh)

United Nations/Geneva, Sep 30 (PTI) The World Health Organization (WHO) has said that Bharat Biotech’s anti-Covid-19 vaccine, Covaccine, has been requested by the company to be listed (EUL) for emergency use. The decision will be taken in October.

The process of evaluation of the vaccine is “ongoing”. Bharat Biotech had sent an offer of interest (EOI) for its vaccine on April 19.

A new document dated September 29 on the WHO website ‘Status of Anti-Covid-19 Vaccines under the WHO EUL/PQ Assessment Process’ states that a decision on Bharat Biotech’s covaccine will be made in “October 2021”.

The WHO said it had started reviewing the vaccine data on July 6. According to the organization, the process of requesting WHO for pre-qualification or listing of vaccines for use in an emergency is confidential. If the product submitted for assessment meets the criteria required for listing, WHO will publish the results widely.


According to the agency, the duration of the EUL process depends on the quality of the data submitted by the vaccine manufacturer and whether the data meets WHO criteria.

Bharat Biotech’s Covaccine and AstraZeneca and Oxford University’s CoviShield vaccine are the two most widely used vaccines in India.

Bharat Biotech said earlier this month that it has submitted all data related to the vaccine for emergency use list (EUL) to the WHO and is now awaiting a response from the global health organisation.

Bharat Biotech had tweeted, “Covacine clinical trial data was fully compiled and available in June 2021. All data for the Emergency Use List (EUL) application was submitted to the World Health Organization in early July. We have responded to the clarifications sought by WHO and await further feedback.

Bharat Biotech said that the company is doing its best to get the WHO EUL at the earliest.


Show More

Related Articles

Leave a Reply

Back to top button